Navigation Links
Cleveland Clinic researchers investigating potential drug for treatment of Alzheimer's disease
Date:8/31/2012

Friday, Aug. 31, 2012, Cleveland: A compound developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease, according to a study by researchers at Cleveland Clinic's Lerner Research Institute and Anesthesiology Institute.

"Cleveland Clinic dedicated two years of research into the examination of this compound and our findings show it could represent a novel therapeutic target in the treatment of Alzheimer's disease," said Mohamed Naguib, M.D., Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine. "Development of this compound as a potential drug for Alzheimer's would take many more years, but this is a promising finding worthy of further investigation."

In a study published online in the Neurobiology of Aging, the compound MDA7 induced beneficial immune responses that limited the development of Alzheimer's disease. Treatment with the compound restored cognition, memory and synaptic plasticity a key neurological foundation of learning and memory in an animal model.

Neuroinflammation is an important mechanism involved in the progression of Alzheimer's disease. The MDA7 compound has anti-inflammatory properties that act on the CB2 receptor one of the two cannabinoid receptors in the body but without the negative side effects normally seen with cannabinoid compounds.

Alzheimer's disease is an irreversible, fatal brain disease that slowly destroys memory and thinking skills. About 5 million people in the United States have Alzheimer's disease. With the aging of the population, and without successful treatment, there will be 16 million Americans and 106 million people worldwide with Alzheimer's by 2050, according to the 2011 Alzheimer's Disease Facts and Figures report from the Alzheimer's Association.


'/>"/>

Contact: Joe Milicia
milicij2@ccf.org
216-636-5873
Cleveland Clinic
Source:Eurekalert

Page: 1

Related medicine news :

1. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
2. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
3. Cleveland Clinic Florida receives approval for transplant programs at Weston Facilities
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. First targeted nanomedicine to enter human clinical studies
6. Clinical insight improves treatment with new lung cancer drug
7. Clinical news alert from the American Academy of Orthopaedic Surgeons
8. Mayo Clinic launches whole genome breast cancer study
9. Mayo Clinic offers newly approved treatment for acid reflux disease
10. NYU Langone experts present research, clinical advances at neurosurgeons meeting
11. Mayo Clinic breast cancer study finds new type of mutation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... According to an article published May 5th on ... concerned about their breath. In fact, it found that more than a third cited unappealing ... caused temporarily by pungent foods or a failure to brush after meals, can typically be ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Horizon Foundation for New ... initiative to improve oral health-related awareness, education, prevention and treatment for young people. ... and promote best practices in 10 New Jersey counties where dental health needs ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... announces that Lake City Bank has selected IFN as a fiber transport provider. ... resulting in increased efficiencies and reduced costs. , “IFN provides fiber ...
(Date:5/25/2016)... O'Fallon, MO (PRWEB) , ... May 25, 2016 , ... ... located in Woodlawn Plaza at 8618 Mexico Road, O’Fallon, MO 63366. He serves patients ... and cosmetic treatments . Dr. Schwarz’s success is reflected in the superior ...
(Date:5/25/2016)... California (PRWEB) , ... May 25, 2016 , ... ... interest group ADDMI - “Advancing Drug Development through Molecular Imaging.” The focus of ... of the current drug discovery and development pipeline issues. Through ADDMI-IG WMIS will ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today announced ... for wounds and infections. This test ensures discovery ... select viruses. The test requires only a simple swab ... David G. Bostwick , MD, Chief ... facilitate wound healing: "We are excited to make ...
(Date:5/25/2016)... May 25, 2016 ReportsnReports.com ... research report that provides an overview on therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:5/24/2016)... , May 24, 2016   ... demonstrating non-inferiority in overall bowel cleansing and superiority in ... c leansing of the ... ) , Norgine B.V. today announced new positive ... PEG and ascorbate bowel preparation) versus standard 2 litre PEG with ...
Breaking Medicine Technology: